Atrys grows nearly 10% driven by Latin America and its oncology division
Atrys Health raised its revenue 9.7% in the first nine months of the year to 117 million euros, driven by its Latin American business and its oncology division. Revenue in Latin America grew 28% to 42 million, after more than doubling sales in Mexico. Ebitda rose 18% to 14 million and the company confirmed its guidance. Net financial debt stood at 37.5 million euros as of September 30, down 78%.
In 30 seconds
- Revenue of 117 million euros through September, up 9.7%
- Latin America billed 42 million (+28%) and Mexico more than doubled its revenue
- Ebitda rose 18% to 14 million euros
IASummary generated by artificial intelligence from a story by Expansión. It may contain errors: the original source prevails.





Comments
Be respectful. Comments reported by several people are hidden until a moderator reviews them.
You do not need an account to read, only to comment. Sign in with a code sent to your email or with your Google account. We only show the name you choose, never your email.